Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia-Reference-Cited by-同舟云学术

Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia

Published:2003-03-18 Issue:7 Volume:97 Page:1721-1731
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Tsimberidou Apostolia-Maria,Stavroyianni Niki,Viniou Nora,Papaioannou Maria,Tiniakou Maria,Marinakis Theodoros,Skandali Anastasia,Sakellari Ioanna,Yataganas Xenophon,

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference52 articles.

1. A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of Cancer and Leukemia Group B

2. Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B

3. Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of allo-SCT, auto-SCT and chemotherapy for the treatment of patients with low- or intermediate-risk acute myeloid leukemia: a network meta-analysis;Stem Cell Research & Therapy;2024-05-31

2. Acute myeloid leukemia: negative prognostic impact of early blast persistence can be in part overcome by a later remission prior to post-induction therapy;Haematologica;2021-11-11

3. Reconstitución de los linfocitos T y células NK después del trasplante alogénico de células progenitoras hematopoyéticas (TCPH);Revista Mexicana de Patología Clínica y Medicina de Laboratorio;2021

4. Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia;Leukemia;2016-02-09

5. Long-term outcomes of patients with intermediate-risk acute myeloid leukemia treated with autologous hematopoietic cell transplant in first complete remission;Leukemia & Lymphoma;2016-01-04